Paul J. Chang, MD, loves live jazz, hates the ballet—and extends his taste to two different means of wringing useful business intelligence from medical imaging informatics.

When it comes to the federal meaningful use program, keep your eye on the prize—not the incentive dollars, advised Doug Fridsma, MD, former director, office of science and technology in the Office of the National Coordinator. With complexity rising and dollars declining, the greater objective in your deployment of health IT should be preparation for payment reform.

The United Kingdom’s National Health Service (NHS) is embarking on an ambitious gene-sequencing project with 11 genomics institutions in England. The objective is to find targeted treatments for a spectrum of illnesses.

Singapore-based Zecotek Photonics, makers of industrial imaging technologies, announced today that the company has settled a lawsuit brought against Philips and Saint Gobain over patent infringement regarding new PET detector technology.

High-grade astrocytoma is a particularly aggressive form of glioma. Parameters of PET imaging such as the minimal time-to-peak could help clinicians narrow in on the best line of treatment for each patient, according to a study published Dec. 23 in the Journal of Nuclear Medicine.

The chief executive officer of Park Avenue hedge fund Third Point, is set to donate $15 million to Mount Sinai Hospital and the Icahn School of Medicine in New York City for a new research institute devoted to studying Alzheimer’s disease.

One gene in particular could be the key master for proper brain development, researchers from the Agency for Science, Technology and Researc

A quantitative PET measurement known as total lesion glycolysis could help clinicians make informed prognoses for patients with a stage of non-small lung cancer, according to a study published online Dec. 18 in the Journal of Nuclear Medicine.